Julia Niezgoda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Julia Niezgoda has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Agnieszka Bullmann
Szpital Specjalistyczny im. F. Ceynowy, ul. dr. Alojzego Jagalskiego 10, 84-200 Wejherowo, Poland
4 shared publications - Julia Baran
University Clinical Hospital in Białystok, ul. M. C. Skłodowskiej 24a, 15-276 Białystok, Poland
4 shared publications - Karolina Wojciechowska
Śniadeckiego Voivodeship Hospital in Bialystok, ul. M. C. Skłodowskiej 26, 15-278 Białystok, Poland
4 shared publications - Katarzyna Woroniecka
Medical University of Białystok, ul. Jana Kilińskiego 1, 15-089 Białystok, Poland
4 shared publications - Tomasz Skłodowski
Medical University of Białystok, ul. Jana Kilińskiego 1, 15-089 Białystok, Poland
4 shared publications - Wiktor Warych
Śniadeckiego Voivodeship Hospital in Bialystok, ul. M. C. Skłodowskiej 26, 15-278 Białystok, Poland
4 shared publications
Latest Publications
- Open Access
- 5 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 53, 70252
Depression and Anxiety as Aspects of Mental Health in Celiac Disease: A Systematic Review and Meta-Analytical Synthesis
Background:Celiac disease (CD) is a chronic immune-mediated disorder with significant extraintestinal manifestations, including neuropsychiatric symptoms. Depression and anxiety are among the most frequently reported and may substantially affect quality of life. Aim:This review aimed to evaluate the prevalence of depressive and anxiety symptoms in adults and children with CD and to assess the influence of adherence to a GFD on psychiatric outcomes. Material and Methods:A structured narrative review with meta-analytical synthesis was conducted using studies identified through PubMed/MEDLINE, Scopus, and Web of Science. Observational studies, clinical cohorts, and existing meta-analyses were included. Findings were integrated narratively, considering age, disease status, and dietary adherence. Results:Depressive symptoms were consistently more prevalent in individuals with CD, particularly in untreated or newly diagnosed patients. Partial improvement was observed following initiation of a gluten-free diet although symptoms often persisted. Findings regarding anxiety were heterogeneous. Psychiatric outcomes were influenced by disease activity, age, nutritional status, and psychosocial factors. Conclusions:Depression and anxiety are clinically relevant but often underrecognized components of CD. A GFD may alleviate psychological distress but does not fully eliminate psychiatric morbidity, supporting the need for routine mental health screening and multidisciplinary care.
- 5 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 53, 70252
Open AccessDepression and Anxiety as Aspects of Mental Health in Celiac Disease: A Systematic Review and Meta-Analytical Synthesis
Background:Celiac disease (CD) is a chronic immune-mediated disorder with significant extraintestinal manifestations, including neuropsychiatric symptoms. Depression and anxiety are among the most frequently reported and may substantially affect quality of life. Aim:This review aimed to evaluate the prevalence of depressive and anxiety symptoms in adults and children with CD and to assess the influence of adherence to a GFD on psychiatric outcomes. Material and Methods:A structured narrative review with meta-analytical synthesis was conducted using studies identified through PubMed/MEDLINE, Scopus, and Web of Science. Observational studies, clinical cohorts, and existing meta-analyses were included. Findings were integrated narratively, considering age, disease status, and dietary adherence. Results:Depressive symptoms were consistently more prevalent in individuals with CD, particularly in untreated or newly diagnosed patients. Partial improvement was observed following initiation of a gluten-free diet although symptoms often persisted. Findings regarding anxiety were heterogeneous. Psychiatric outcomes were influenced by disease activity, age, nutritional status, and psychosocial factors. Conclusions:Depression and anxiety are clinically relevant but often underrecognized components of CD. A GFD may alleviate psychological distress but does not fully eliminate psychiatric morbidity, supporting the need for routine mental health screening and multidisciplinary care.
- Open Access
- 14 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 51
The role of ginger (Zingiber officinale) in the management of nausea and vomiting
Nausea and vomiting are common and clinically relevant symptoms associated with a wide range of medical conditions, including chemotherapy and radiotherapy, surgical procedures, pregnancy, and gastrointestinal disorders. Their pathophysiology involves complex interactions between central and peripheral nervous system pathways, neurotransmitters, inflammatory mediators, and gastrointestinal motility. Ginger (Zingiber officinale), a medicinal plant traditionally used to alleviate gastrointestinal discomfort, contains bioactive compounds such as gingerols and shogaols that exhibit anti-inflammatory, prokinetic, and neuro-modulatory properties. This article provides a narrative review of current clinical and experimental evidence regarding the role of ginger in the management of nausea and vomiting, with particular emphasis on chemotherapy-induced nausea and vomiting, postoperative nausea, nausea of pregnancy, and selected gastrointestinal conditions.
- 14 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 51
Open AccessThe role of ginger (Zingiber officinale) in the management of nausea and vomiting
Nausea and vomiting are common and clinically relevant symptoms associated with a wide range of medical conditions, including chemotherapy and radiotherapy, surgical procedures, pregnancy, and gastrointestinal disorders. Their pathophysiology involves complex interactions between central and peripheral nervous system pathways, neurotransmitters, inflammatory mediators, and gastrointestinal motility. Ginger (Zingiber officinale), a medicinal plant traditionally used to alleviate gastrointestinal discomfort, contains bioactive compounds such as gingerols and shogaols that exhibit anti-inflammatory, prokinetic, and neuro-modulatory properties. This article provides a narrative review of current clinical and experimental evidence regarding the role of ginger in the management of nausea and vomiting, with particular emphasis on chemotherapy-induced nausea and vomiting, postoperative nausea, nausea of pregnancy, and selected gastrointestinal conditions.
- Open Access
- 4 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 51, 68504
The Role of Myo-Inositol in the Management of Metabolic and Reproductive Sequelae of Polycystic Ovary Syndrome: A Comprehensive Review of the Current State of Knowledge
Polycystic Ovary Syndrome (PCOS) represents a heterogeneous and multifaceted endocrinopathy, characterized by extensive metabolic implications, affecting a substantial global cohort of reproductive-age women. Central to its pathogenesis is insulin resistance (IR) and compensatory hyperinsulinemia, which drive both metabolic dysfunction and reproductive failures. Myo-inositol (MI), acting as a vital second messenger for both insulin and follicle-stimulating hormone (FSH), has emerged as a cornerstone therapeutic agent. This comprehensive review evaluates the clinical efficacy of MI, particularly when administered in the physiological 40:1 ratio with D-chiro-inositol (DCI). We analyze its impact on glycemic profiles, hormonal stabilization, and the enhancement of oocyte competence. Based on the 2023 International Evidence-based Guidelines and recent clinical trials, MI represents a safe, well-tolerated, and effective alternative to traditional pharmacological interventions, providing a holistic approach to PCOS management.
- 4 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 51, 68504
Open AccessThe Role of Myo-Inositol in the Management of Metabolic and Reproductive Sequelae of Polycystic Ovary Syndrome: A Comprehensive Review of the Current State of Knowledge
Polycystic Ovary Syndrome (PCOS) represents a heterogeneous and multifaceted endocrinopathy, characterized by extensive metabolic implications, affecting a substantial global cohort of reproductive-age women. Central to its pathogenesis is insulin resistance (IR) and compensatory hyperinsulinemia, which drive both metabolic dysfunction and reproductive failures. Myo-inositol (MI), acting as a vital second messenger for both insulin and follicle-stimulating hormone (FSH), has emerged as a cornerstone therapeutic agent. This comprehensive review evaluates the clinical efficacy of MI, particularly when administered in the physiological 40:1 ratio with D-chiro-inositol (DCI). We analyze its impact on glycemic profiles, hormonal stabilization, and the enhancement of oocyte competence. Based on the 2023 International Evidence-based Guidelines and recent clinical trials, MI represents a safe, well-tolerated, and effective alternative to traditional pharmacological interventions, providing a holistic approach to PCOS management.
- Open Access
- 27 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
The Role of Curcumin in Obesity: Mechanisms and Metabolic Implications
Obesity is a complex, multifactorial chronic disease associated with metabolic, inflammatory, cardiovascular, renal, and gastrointestinal complications. Increasing interest has been directed toward bioactive dietary compounds with potential anti-obesity properties. Curcumin, the principal polyphenolic compound derived from Curcuma longa, has been extensively investigated for its metabolic, anti-inflammatory, antioxidant, and regulatory effects on adipose tissue, liver metabolism, insulin sensitivity, and gut microbiota. This review summarizes and critically analyzes available evidence regarding the role of curcumin in obesity, drawing on in vitro studies, animal models, clinical trials, and mechanistic investigations. The findings indicate that curcumin supplementation is associated with attenuation of weight gain, adipogenesis, inflammation, insulin resistance, lipid accumulation, and obesity-related organ dysfunction through multiple molecular pathways. However, most available evidence originates from preclinical models, while clinical data remain limited and heterogeneous, highlighting the need for cautious interpretation of translational relevance. Further well-designed, large-scale clinical studies are required to clarify curcumin’s therapeutic potential in obesity management.
- 27 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
Open AccessThe Role of Curcumin in Obesity: Mechanisms and Metabolic Implications
Obesity is a complex, multifactorial chronic disease associated with metabolic, inflammatory, cardiovascular, renal, and gastrointestinal complications. Increasing interest has been directed toward bioactive dietary compounds with potential anti-obesity properties. Curcumin, the principal polyphenolic compound derived from Curcuma longa, has been extensively investigated for its metabolic, anti-inflammatory, antioxidant, and regulatory effects on adipose tissue, liver metabolism, insulin sensitivity, and gut microbiota. This review summarizes and critically analyzes available evidence regarding the role of curcumin in obesity, drawing on in vitro studies, animal models, clinical trials, and mechanistic investigations. The findings indicate that curcumin supplementation is associated with attenuation of weight gain, adipogenesis, inflammation, insulin resistance, lipid accumulation, and obesity-related organ dysfunction through multiple molecular pathways. However, most available evidence originates from preclinical models, while clinical data remain limited and heterogeneous, highlighting the need for cautious interpretation of translational relevance. Further well-designed, large-scale clinical studies are required to clarify curcumin’s therapeutic potential in obesity management.